SBSB
CELG

Sullivan, Bruyette, Speros & Blaney’s Celgene Corp CELG Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,126
Closed -$112K – 356
2019
Q3 		$112K Buy
+1,126
New +$107K 0.01% 315
2017
Q4 		– Sell
-1,511
Closed -$220K – 171
2017
Q3 		$220K Buy
+1,511
New +$206K 0.02% 151

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's CELG Position: Q4 2019 in Review

Sullivan, Bruyette, Speros & Blaney sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,126 shares — an estimated $112K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in CELG in Q3 2017 and held it in 2 quarters. The position peaked at $220K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Sullivan, Bruyette, Speros & Blaney reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Sullivan, Bruyette, Speros & Blaney sold 1,126 Celgene Corp shares in Q4 2019, an estimated $112K.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Celgene Corp in Q3 2017 and held it in 2 quarters.
  • Sullivan, Bruyette, Speros & Blaney's Celgene Corp position peaked at $220K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q4 2019, filed 13 Feb 2020.